LC/MS/MS Peptide Mapping Comparison of Innovator and Biosimilars of Rituximab
Applications | 2019 | Agilent TechnologiesInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesPharma & Biopharma, Proteomics
ManufacturerAgilent Technologies
Key wordsinnovator, peptide, counts, chain, mapping, biosimilar, charge, unmodified, ptms, heavy, assaymap, ttppvldsdgsfflyskl, mabs, bravo, biosimilars, oxidized, mass, slslspgk, slslspg, acquisition, precursor, agilent, deamidation, min, differences, light, time, qtpgrglewigaiypgngdtsynqk, vvsvltvlhqdwlngkey, deamidated, cqas, masshunter, bioconfirm, workflow, sequence, mab, trypsin, histograms, gfypsdiavewesngqpennyk, relative, levels, monoclonal, coverage, were, compare, iterative, comparability, voltage, quantification, rituximab
Similar PDF
Peptide Mapping of Innovator and Biosimilar Monoclonal Antibody Using an Agilent 1290 Infinity UHPLC Coupled to an Agilent 6550 iFunnel Q-TOF LC/MS System
2017|Agilent Technologies|Applications
Peptide Mapping of Innovator and Biosimilar Monoclonal Antibody Using an Agilent 1290 Infinity UHPLC Coupled to an Agilent 6550 iFunnel Q-TOF LC/MS System Application Note Author Introduction Ravindra Gudihal Monoclonal antibodies (mAbs) are becoming one of the important classes of…
Key words
peptide, peptideinnovator, innovatorbiosimilar, biosimilardeamidation, deamidationcounts, countsoxidation, oxidationdltmisr, dltmisrmapping, mappingtrypsin, trypsinunmodified, unmodifiedoxi, oxiions, ionsheight, heightcharge, chargedem
In-depth Peptide Mapping with Iterative MS/MS Acquisition on the Agilent 6545XT AdvanceBio LC/Q‑TOF
2020|Agilent Technologies|Applications
Application Note Biotherapeutics and Biosimilars In-depth Peptide Mapping with Iterative MS/MS Acquisition on the Agilent 6545XT AdvanceBio LC/Q‑TOF Authors Introduction Linfeng Wu and David L. Wong Agilent Technologies, Inc. Santa Clara, CA, USA Therapeutic monoclonal antibodies (mAbs) represent one of…
Key words
ntaylqmnslr, ntaylqmnslriterative, iterativepeptide, peptidemapping, mappingcounts, countsauto, autoacquisition, acquisitionassaymap, assaymapcharge, chargeprecursors, precursorseccs, eccsmass, massbravo, bravoisoasp, isoaspagilent
Enhancing The Quality Of Peptide Mapping Separation For The Analysis Of PTM
2017|Agilent Technologies|Applications
Enhancing The Quality Of Peptide Mapping Separation For The Analysis Of PTM Application Note Biotherapeutics and Biosimilars Author Introduction Suresh Babu C.V. Post-translational modifications (PTMs) on proteins such as monoclonal antibodies (mAbs) are critical quality attributes (CQAs) that define the…
Key words
peptide, peptidecounts, countsntaylqmnslr, ntaylqmnslradvancebio, advancebiodltmisr, dltmisrmab, mabeeeqynstr, eeeqynstrptms, ptmsdeamidated, deamidatedplus, plusdigest, digestmapping, mappingseparation, separationnonoxidized, nonoxidizedtryptic
An Integrated Workflow for Peptide Mapping of Monoclonal Antibodies
2017|Agilent Technologies|Applications
An Integrated Workflow for Peptide Mapping of Monoclonal Antibodies Application Note Biotherapeutics and Biosimilars Authors Introduction David L. Wong Monoclonal antibodies (mAbs) represent one of the fastest growing classes of drugs in the pharmaceutical industry. As a protein drug, the…
Key words
peptide, peptidemab, mabmapping, mappingcounts, countsassaymap, assaymapsgtasvvcllnnfypr, sgtasvvcllnnfypracquisition, acquisitionworkflow, workflowcharge, chargewere, weresequence, sequencenist, nistdigestion, digestiondiqmtqspstlsasvgdrvtitcsassr, diqmtqspstlsasvgdrvtitcsassrmtqspstlsasvgdrvtitcsassr